Global Recombinant Human Granulocyte Colony-Stimulating Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published On: December 2019 | Report ID: 221753 | Category: Pharmaceuticals and HealthcarePages: 109

Description

Scope of the Report:

The worldwide market for Recombinant Human Granulocyte Colony-Stimulating is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Recombinant Human Granulocyte Colony-Stimulating in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen

Huaxin

Kyowa Hakko Kirin

Qilu Pharmaceutical

Hangzhou Jiuyuan

Shijiazhuang Pharmaceutical

Sinovac

Amoytop Biotech

Gensci

Triprime

Zhaoke

Kawin

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Lenograstim (Granocyte)

Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

Others

Market Segment by Applications, can be divided into

Chemotherapy Induced Neutropenia

Before Blood Donation

Stem Cell Transplants

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Recombinant Human Granulocyte Colony-Stimulating product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Recombinant Human Granulocyte Colony-Stimulating, with price, sales, revenue and global market share of Recombinant Human Granulocyte Colony-Stimulating in 2017 and 2018.

Chapter 3, the Recombinant Human Granulocyte Colony-Stimulating competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Recombinant Human Granulocyte Colony-Stimulating breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Recombinant Human Granulocyte Colony-Stimulating market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Recombinant Human Granulocyte Colony-Stimulating sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Recombinant Human Granulocyte Colony-Stimulating Introduction

1.2 Market Analysis by Type

1.2.1 Lenograstim (Granocyte)

1.2.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Chemotherapy Induced Neutropenia

1.3.2 Before Blood Donation

1.3.3 Stem Cell Transplants

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Huaxin

2.2.1 Business Overview

2.2.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Kyowa Hakko Kirin

2.3.1 Business Overview

2.3.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Qilu Pharmaceutical

2.4.1 Business Overview

2.4.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Hangzhou Jiuyuan

2.5.1 Business Overview

2.5.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Shijiazhuang Pharmaceutical

2.6.1 Business Overview

2.6.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Sinovac

2.7.1 Business Overview

2.7.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Amoytop Biotech

2.8.1 Business Overview

2.8.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Gensci

2.9.1 Business Overview

2.9.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Triprime

2.10.1 Business Overview

2.10.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Zhaoke

2.11.1 Business Overview

2.11.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Kawin

2.12.1 Business Overview

2.12.2 Recombinant Human Granulocyte Colony-Stimulating Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share in 2018

3.3.2 Top 6 Recombinant Human Granulocyte Colony-Stimulating Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Recombinant Human Granulocyte Colony-Stimulating Market Analysis by Regions

4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Regions

4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Regions (2014-2019)

4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Regions (2014-2019)

4.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

4.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

4.5 South America Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

5 North America Recombinant Human Granulocyte Colony-Stimulating by Country

5.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country

5.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019)

5.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019)

5.2 United States Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

5.3 Canada Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

5.4 Mexico Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

6 Europe Recombinant Human Granulocyte Colony-Stimulating by Country

6.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country

6.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019)

6.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019)

6.2 Germany Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

6.3 UK Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

6.4 France Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

6.5 Russia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

6.6 Italy Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

7 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating by Country

7.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019)

7.2 China Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

7.3 Japan Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

7.4 Korea Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

7.5 India Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

8 South America Recombinant Human Granulocyte Colony-Stimulating by Country

8.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country

8.1.1 South America Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019)

8.1.2 South America Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019)

8.2 Brazil Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

8.3 Argentina Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

8.4 Colombia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

9 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating by Countries

9.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

9.3 Turkey Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

9.4 Egypt Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

9.5 Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

9.6 South Africa Recombinant Human Granulocyte Colony-Stimulating Sales and Growth Rate (2014-2019)

10 Global Recombinant Human Granulocyte Colony-Stimulating Market Segment by Type

10.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales and Market Share by Type (2014-2019)

10.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Type (2014-2019)

10.2 Lenograstim (Granocyte) Sales Growth and Price

10.2.1 Global Lenograstim (Granocyte) Sales Growth (2014-2019)

10.2.2 Global Lenograstim (Granocyte) Price (2014-2019)

10.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Sales Growth and Price

10.3.1 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Sales Growth (2014-2019)

10.3.2 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Price (2014-2019)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2014-2019)

10.4.2 Global Others Price (2014-2019)

11 Global Recombinant Human Granulocyte Colony-Stimulating Market Segment by Application

11.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2014-2019)

11.2 Chemotherapy Induced Neutropenia Sales Growth (2014-2019)

11.3 Before Blood Donation Sales Growth (2014-2019)

11.4 Stem Cell Transplants Sales Growth (2014-2019)

11.5 Others Sales Growth (2014-2019)

12 Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Growth Rate (2019-2024)

12.2 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Regions (2019-2024)

12.2.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.2.3 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.2.4 South America Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.2.5 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Forecast (2019-2024)

12.3 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Type (2019-2024)

12.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2019-2024)

12.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Type (2019-2024)

12.4 Recombinant Human Granulocyte Colony-Stimulating Market Forecast by Application (2019-2024)

12.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2019-2024)

12.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.